Enhancement of transdermal delivery of 6-β-naltrexol via a codrug linked to hydroxybupropion
- 28 June 2006
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 113 (2) , 137-145
- https://doi.org/10.1016/j.jconrel.2006.04.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- In Vivo Characterization of 6β-Naltrexol, an Opioid Ligand with Less Inverse Agonist Activity Compared with Naltrexone and Naloxone in Opioid-Dependent MiceThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Behavioral naltrexone therapyJournal of Substance Abuse Treatment, 2002
- In vivo and in vitro potency studies of 6ß‐naltrexol, the major human metabolite of naltrexoneAddiction Biology, 2002
- Serum 6-Beta-Naltrexol Levels Are Related to Alcohol Responses in Heavy DrinkersAlcohol, Clinical and Experimental Research, 2000
- Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled TrialNeuropsychopharmacology, 2000
- Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addictsDrug and Alcohol Dependence, 1998
- Naltrexone and Alcohol DependenceArchives of General Psychiatry, 1997
- Naltrexone and Coping Skills Therapy for Alcohol DependenceArchives of General Psychiatry, 1992
- Naltrexone in the Treatment of Alcohol DependenceArchives of General Psychiatry, 1992
- Naltrexone: Disposition, metabolism, and effects after acute and chronic dosingClinical Pharmacology & Therapeutics, 1976